Item request has been placed!
×
Item request cannot be made.
×
Processing Request
New molecular entities/biologics.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Subject Terms:
- Subject Terms:
- Abstract:
The article provides information related to several drug approvals by the U.S. Food and Drug Administration. A monoclonal antibody called Ranibizumab was approved for the treatment of age-related macular degeneration. An approval was granted to Darunavir, a protease inhibitor used for the treatment of HIV infection in antiretroviral treatment-experienced adult patients. Also approved was Dasatinib, a kinase inhibitor used for the treatment of several forms of leukemia.
No Comments.